SynthesisJournal of epidemiology and global health2025
Distribution of Mycobacterium Tuberculosis Lineages and Sublineages by Drug Profile in Ethiopia: A Systematic Review and Meta-Analysis.
Synthesis in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMycobacterium tuberculosis lineages exhibit variability in geographic distribution, transmissibility, and disease phenotype. Ethiopia is one of the countries with the highest prevalence of tuberculosis. The aim of this study was to summarize the proportion of lineages and sublineages by drug resistance profile and TB type.
methodsThe results were reported in accordance with the PRISMA guidelines. The study protocol was registered with ID CRD42024498336. Studies reporting Mtb lineages and sublineages with drug resistance profiles published between March 2010 and June 2024 were included. I² was used to evaluate heterogeneity. A p-value less than 0.05 and an I² value greater than 75% indicated significant heterogeneity.
resultsA total of 5554 Mycobacterium tuberculosis strains were included from 32 studies. The percentage of East African Indian was 26.8% (95% CI: 22.6-30.6), and Euro-American was 64.1% (95% CI: 59.6-68.4) among all TB cases. In studies that included only multidrug- or rifampicin-resistant cases, the percentage of East African Indian was 33.78% (95% CI: 27.81-39.74), while Euro-American was 52.96% (95% CI: 41.32-64.61). Euro-American, followed by East African-Indian, was the predominant lineage across locations and TB types; however, East African-Indian was significantly higher in the Amhara region for both pulmonary TB and extra-pulmonary TB (EPTB) than in Addis Ababa. As defined by spoligotyping, T3ETH (28.22%), CAS1-Kili (18.13%), and T1 (11.54%) were the three most common sublineages among MDR/RR TB cases, while CAS1-Delhi (20.23%), T1 (16.71%), and T3ETH (13.50%) were the most common among susceptible cases.
conclusionThe three most prevalent Mtb sublineages significantly contribute to the TB and drug resistance epidemic; such data are vital for prioritizing contact tracing. The variation in EAI percentage among EPTB cases across regions likely reflects the influence of genetic variation on the prevalence of EPTB. This suggests a need for genomic surveillance to inform the development of more targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.